Singapore markets closed

Medexus Pharmaceuticals Inc. (MEDXF)

OTC Markets OTCQX - OTC Markets OTCQX Delayed price. Currency in USD
Add to watchlist
1.5600+0.0100 (+0.65%)
At close: 03:18PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Cash flows from operating activities
Net income
-214
-214
1,221
-2,879
-28,264
-
Depreciation & amortisation
5,806
5,806
6,081
6,145
5,978
-
Deferred income taxes
320
320
-6,262
-941
-3,237
-
Stock-based compensation
469
469
1,216
1,883
1,270
-
Change in working capital
2,341
2,341
-15,262
4,730
182
-
Accounts receivable
-1,677
-1,677
-8,236
4,430
-3,505
-
Inventory
-6,753
-6,753
-1,987
-6,660
-9
-
Other working capital
18,448
18,448
-1,806
-8,894
-5,714
-
Other non-cash items
10,605
10,605
13,499
12,223
9,819
-
Net cash provided by operating activities
18,714
18,714
-1,444
-1,180
5,041
-
Cash flows from investing activities
Investments in property, plant and equipment
-266
-266
-362
-7,714
-10,755
-
Acquisitions, net
-3,212
-3,212
-1,359
-482
-952
-
Net cash used for investing activities
-3,478
-3,478
-1,721
-8,196
-11,707
-
Cash flows from financing activities
Debt repayment
-43,988
-43,988
-24,724
-164
-369
-
Common stock issued
7,606
7,606
0
0
22,635
-
Common stock repurchased
-
-
-
-
-
-2,810
Dividends paid
0
0
0
0
0
-
Other financing activities
-
-
-
-
-297
-365
Net cash used provided by (used for) financing activities
-23,048
-23,048
6,405
663
18,683
-
Net change in cash
-7,812
-7,812
3,240
-8,713
12,017
-
Cash at beginning of period
13,069
13,069
10,018
18,704
5,233
-
Cash at end of period
5,255
5,255
13,069
10,018
18,704
-
Free cash flow
Operating cash flow
18,714
18,714
-1,444
-1,180
5,041
-
Capital expenditure
-266
-266
-362
-7,714
-10,755
-
Free cash flow
18,448
18,448
-1,806
-8,894
-5,714
-